Family Medicine · Oklahoma City, OK
NPI
1467430900
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
4
Medicare group memberships
Hospitals
2
Hospital affiliations
5721 NW 132nd St
Oklahoma City, OK, 73142
Phone (405) 557-1200
Groups this clinician bills Medicare through
Medicare paid, 2024
$442K
6,187 services
Medicare patients, 2024
803
Average age 77
Drug cost, 2024
$5.2M
55,227 prescriptions
Company payments, 2025
$284
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ronald Cable was code 99309 (snf e&m), 3,268 times for 540 patients. In total Ronald Cable billed 6,187 services in 25 codes, and Medicare paid $442K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-02-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99309 SNF E&M | Office | 3,268 | 540 | $73.48 | $240K |
| 99309 SNF E&M | Facility | 888 | 130 | $75.49 | $67K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 510 | 129 | $46.33 | $24K |
| 99305 SNF E&M | Office | 496 | 368 | $91.99 | $46K |
| 99421 Office/Outpatient Services | Office | 216 | 128 | $11.10 | $2,398 |
| 99349 Home E&M - New and Established | Office | 162 | 20 | $84.22 | $14K |
| 99305 SNF E&M | Facility | 131 | 98 | $92.16 | $12K |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 103 | 102 | $35.04 | $3,609 |
| 99308 SNF E&M | Office | 64 | 57 | $52.55 | $3,363 |
| 99496 Chronic, Principal, and Transitional Care Management | Office | 57 | 53 | $199.12 | $11K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 55 | 55 | $118.08 | $6,494 |
| 99422 Office/Outpatient Services | Office | 42 | 35 | $21.74 | $913 |
| G0179 Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 38 | 13 | $29.21 | $1,110 |
| 99497 Care Management/Coordination | Office | 25 | 25 | $70.30 | $1,757 |
| 96138 Behavioral Health Services | Office | 24 | 24 | $19.42 | $466 |
By year: 2022 $322K for 4,846 services; 2023 $405K for 6,106 services; 2024 $442K for 6,187 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ronald Cable prescribed most often to Medicare patients was Atorvastatin Calcium, with 2,272 prescriptions and refills. In total Ronald Cable wrote 55,227 Medicare prescriptions that cost $5.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 2,272 | 2,280 | 368 | $37K |
| Eliquis Apixaban | 2,040 | 2,052 | 217 | $564K |
| Levothyroxine Sodium Generic | 1,948 | 1,956 | 265 | $25K |
| Gabapentin Generic | 1,623 | 1,631 | 271 | $33K |
| Furosemide Generic | 1,528 | 1,528 | 258 | $11K |
| Pantoprazole Sodium Generic | 1,298 | 1,302 | 224 | $23K |
| Amlodipine Besylate Generic | 1,230 | 1,248 | 223 | $14K |
| Potassium Chloride Generic | 1,109 | 1,109 | 212 | $24K |
| Trazodone Hcl Generic | 1,101 | 1,113 | 191 | $17K |
| Mirtazapine Generic | 994 | 994 | 180 | $16K |
| Lisinopril Generic | 988 | 994 | 175 | $11K |
| Metoprolol Tartrate Generic | 834 | 834 | 162 | $7,843 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 817 | 817 | 220 | $29K |
| Omeprazole Generic | 790 | 794 | 167 | $11K |
| Tamsulosin Hcl Generic | 785 | 787 | 150 | $16K |
Brand drugs: 9,761 claims; generic drugs: 44,913 claims; opioid claims: 2,077.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ronald Cable $284 ($284 in general payments such as food, travel and fees) from 6 companies. The largest payer was ACADIA Pharmaceuticals Inc with $125.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.